Functional Assessment Protocol for the Upper Limb for Pediatric Age

Status Recruiting

Clinical Trial Summary

During data acquisition a trained therapist placed reflective markers on the skin of the participants in the selected body landmarks. The participants will be asked to perform five trial for each upper limb of a determinate functional task for each session.

Clinical Trial Description

Acquired brain injuries (ABIs)and cerebral palsy (CP) can lead to a wide range of impairments, including weakness or paralysis on one side of the body known as hemiplegia. In hemiplegic patients, the rehabilitation of the upper limb skills is crucial, because the recovery has an immediate impact on patient quality of life. Therefore, an accurate upper limb motion analysis may be useful during medical diagnostic-therapeutic process, it is relevant to understand the integrated and synergic motion of the upper limbs for a variety of applications, such as clinical diagnosis, endoprosthesis design, and the evaluation of treatment outcomes. There are many clinical scales used to assess the upper extremity. Most of these use an ordinal-level scoring system, with scores assigned to the patient by the observing physician or therapist. Another way to assess upper limb activity is through kinematics data from 3D motion capture. Kinematics data provide an objective and quantifiable method, as well as allowing the use of several otherwise undetectable metrics: time, velocity, and joint angles. The aim of this study is introducing a new protocol consisting of a marker set, i.e. an innovative and integrated biomechanical model of the human body for the global analysis of upper limb during functional tasks allows for a more detailed evaluation of the motor behavior and its abnormalities to better characterize the functionality of the upper, both on the sagittal, frontal and transversal plane. The development of a new protocol of analysis requires the validation before its definitive and clinical application. More in detail, the validation should be carried out in terms of both comparisons with reference absolute measures and the evaluation of its repeatability with healthy subjects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06400667
Study type	Interventional
Source	IRCCS Eugenio Medea
Contact	Giuseppe Andreoni
Phone	031877350
Email	giuseppe.andreoni@lanostrafamiglia.it
Status	Recruiting
Phase	N/A
Start date	May 18, 2023
Completion date	May 18, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06320626` - Pharmacokinetic-guided Dosing of Emicizumab	Phase 4
Completed	`NCT04011852` - The Role of Chest Electrical Impedance Tomography in the Pediatric Ventilator Weaning
Completed	`NCT03497663` - VIA Family - Family Based Early Intervention Versus Treatment as Usual	N/A
Recruiting	`NCT05016271` - Health Benefits of Air Purifiers in Primary School Students	N/A
Completed	`NCT02551978` - Kids Obesity Prevention Program - Study (KOP)	N/A
Completed	`NCT02240368` - Performance Evaluation of the Depth of Anesthesia Monitors in Pediatric Surgery
Completed	`NCT03946137` - Chest Therapy and Postural Education in Children With Cerebral Palsy	N/A
Completed	`NCT01918020` - Impact Study of Minnesota SNAP-Ed Health and Nutrition Education Programs	N/A
Completed	`NCT01267097` - The PAC Study: Parents as Agents of Change in Pediatric Weight Management	N/A
Recruiting	`NCT04022460` - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed	`NCT05538039` - Reducing Anxiety of Children and Their Parents in the Pre-elective Surgery Process	N/A
Completed	`NCT03156465` - Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants	N/A
Not yet recruiting	`NCT05914324` - Outpatient Pediatric Pulse Oximeters in Africa	N/A
Not yet recruiting	`NCT04827108` - Psychometric Properties of the Chinese Version of PeNAT
Recruiting	`NCT04888195` - Symptom Clusters in Hong Kong Chinese Children With Blood Cancer
Not yet recruiting	`NCT04853303` - VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK	N/A
Completed	`NCT05374902` - Efficacy of Animation, Buzzy, and Multiple Interventions on Pain in Children	N/A
Completed	`NCT04665453` - Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children	N/A
Completed	`NCT04082247` - Healthy Children 2021 Study in Childcare Centers	N/A
Completed	`NCT02858531` - Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.